• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD HEYMAN FOLLOWER COUDE TIP 14 FR., STERILE; DILATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD HEYMAN FOLLOWER COUDE TIP 14 FR., STERILE; DILATION CATHETER Back to Search Results
Model Number 021314
Device Problems Incorrect Measurement (1383); Dull, Blunt (2407)
Patient Problems Tissue Damage (2104); Injury (2348)
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that the tip has been very blunt instead of having a smooth tapered end.This has caused significant damage to the urethral tissue.Per additional information from dr.(b)(6).There was no change in the medical management of the patient who has a more traumatic dilation (damage to urethral tissue) except to leave the post-dilation catheter in longer.
 
Manufacturer Narrative
The reported issue was unconfirmed.The device was returned and visually inspected.Evaluation of the sample noted no obvious defects such as cracks or lumps.The tip of the device was able to pass through french size 13 as required.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use states the following: ¿1.Bard® heyman¿ followers are intended to be used with bardex® councill catheters and bard® heyman¿ filiform catheters.All individual devices are disposable and sold sterile.2.The filiform catheter comes packaged with a disposable stylet to use for insertion.Insert the bard® heyman¿ filiform catheter with stylet in place.The filiform catheter may be placed by inserting through a cystoscope under direct vision.Direct view catheter placement will decrease the number of difficult and possible false passages.3.There is a 3 centimeter orientation marking on the filiform catheter at 30 centimeters from the distal end to assist with placing the filiform catheter in the bladder.Placement of the filiform catheter in the bladder can be determined by removing the stylet and observing urine or aspirating urine with a syringe.If added confirmation is necessary, a radio graph can be taken after injecting radiopaque dye into the filiform catheter.When the filiform catheter has been properly placed, the stylet should be discarded.4.Starting with the smaller sizes, slip the bard® heyman¿ followers (straight or coude) over the filiform catheter.Increase the follower size until the desired dilation is accomplished.5.Slip a bardex® councill catheter over the filiform catheter and when it is in place, inflate balloon.Remove the filiform catheter.If, at a later time, the councill catheter is to be replaced, insert a new filiform catheter prior to removing the councill catheter.The filiform catheter will then guide the new councill catheter into place.After use, this product may be potential biohazard.Handle and dispose of in accordance with accepted medical practice and applicable local, state and federal laws and regulations.Warning: because the filiform catheter may advance with the passage of the followers, a length of the filiform catheter should always appear beyond the proximal end of the follower, otherwise the filiform catheter may be left in the urethra when the follower is withdrawn.".
 
Event Description
It was reported that the tip was very blunt instead of having a smooth tapered end.This allegedly caused significant damage to the urethral tissue.It was later reported by dr.(b)(6) that there was no change in the medical management of the patient who has a more traumatic dilation (damage to urethral tissue) except to leave the post-dilation catheter in longer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD HEYMAN FOLLOWER COUDE TIP 14 FR., STERILE
Type of Device
DILATION CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key7516092
MDR Text Key108317389
Report Number1018233-2018-01758
Device Sequence Number1
Product Code FBW
UDI-Device Identifier00801741075612
UDI-Public(01)00801741075612
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 07/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2022
Device Model Number021314
Device Catalogue Number021314
Device Lot NumberMCBW3409
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/24/2018
Date Manufacturer Received07/03/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-